DEBBANE RAYMOND

SEC Form 4 insider trading activity

DEBBANE RAYMOND has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 4, 2026.

On the most recent filing, DEBBANE RAYMOND is listed as Director at LEXICON PHARMACEUTICALS, INC. Inside the rolling window, DEBBANE RAYMOND reported 7 open-market purchases totaling $723K in LXRX and no open-market sales. The largest disclosed transaction in the window is a purchase of 133,688 LXRX shares on Feb 18, 2026, worth $176K.

Companies traded

Other insiders at LXRX

Insider Buying

$723K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LXRXPurchase$3KFeb 27SEC ↗
LXRXPurchase$147KFeb 25SEC ↗
LXRXPurchase$72KFeb 23SEC ↗
LXRXPurchase$148KFeb 23SEC ↗
LXRXPurchase$76KFeb 18SEC ↗
LXRXPurchase$101KFeb 18SEC ↗
LXRXPurchase$176KFeb 18SEC ↗
Showing 1–7 of 7
1 / 1

Frequently asked questions

How many SEC Form 4 filings has DEBBANE RAYMOND made?

DEBBANE RAYMOND has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.

Which companies does DEBBANE RAYMOND trade?

DEBBANE RAYMOND has filed SEC Form 4 disclosures for 1 company, including LXRX.

When was DEBBANE RAYMOND's most recent SEC Form 4 filing?

DEBBANE RAYMOND's most recent SEC Form 4 filing on Tracefour is dated Jun 4, 2026.

What is DEBBANE RAYMOND's total buy and sell value in the current window?

Inside the rolling retention window, DEBBANE RAYMOND bought $723K and sold $0 based on SEC Form 4 filings.

What was DEBBANE RAYMOND's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 133,688 LXRX shares on 2026-02-18, worth $176K, per SEC Form 4 filings.